During the past decade, Ohio Health conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 7 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio Health" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "OhioHealth" with 3 trials sponsored, "Corvia Medical" with 2 trials sponsored, "CytoDyn, Inc." with 2 trials sponsored and "Tempus Labs" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio Health" #1 collaborator was "Bard Ltd" with 1 trials as a collaborator, "Claremont McKenna College" with 1 trials as a collaborator, "Denison University" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "High Risk Pregnancy Center, Las Vegas, Nevada" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ohio Health" are "Brain Cancer" (2 trials), "Coronavirus Disease 2019" (2 trials), "Heart Failure" (2 trials), "Metastatic Cancer" (2 trials) and "Pancreatic Cancer" (2 trials). Many other conditions were trialed in "Ohio Health" in a lesser frequency.

Most popular intervention types in "Ohio Health" are "Drug" (16 trials), "Device" (10 trials), "Other" (7 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Leronlimab (700mg)" (2 trials), "Placebo" (2 trials), "ABI" (1 trials) and "Acthar" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio Health" are 30 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ohio Health". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ohio Health, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio Health, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".